,,iii #aagth ,,congress #b;d ,session ,s4 ,,res4 #fhc ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,june #af1 #bjbb ,mr4 ,booker 7for himself1 ,mr4 ,brown1 and ,mr4 ,van ,hollen7 submitted the following resolution2 which was referred to the ,committee on ,foreign ,relations ,,resolution ,supporting the goals and ideals of ,world ,sickle ,cell ,awareness ,day4 ,whereas sickle cell disease 7referred to in this preamble as ,,scd7 is a genetically inherited condition present at birth that involves a group of red blood cell disorders and is a major health problem in the ,united ,states and worldwide2 ,whereas the #bjbb theme of ,world ,sickle ,cell ,awareness ,day1 ,shine the ,light on ,sickle ,cell1 is an immediate call to action to improve the health and quality of life for individuals living with ,,scd and their families2 ,whereas1 in #aigb1 ,dr4 ,charles ,whitten established the ,sickle ,cell ,disease ,association of ,america1 which is now headquartered in ,hanover1 ,maryland1 to improve research1 education1 and healthcare for ,,scd patients2 ,whereas1 in #aigb1 ,congress passed the ,national ,sickle ,cell ,anemia ,control ,act 7,public ,law #ib-bid2 #hf ,stat4 #acf71 which provided authority to establish education1 information1 screening1 testing1 counseling1 research1 and treatment programs for ,,scd patients2 ,whereas ,,scd is a genetic mutation that causes a single misspelling in the ,,dna instructions for hemoglobin1 a protein that aids in carrying oxygen in the blood1 which may result in chronic complications related to anemia1 stroke1 infections1 organ failure1 tissue damage1 intense periods of pain referred to as vaso-occlusive crisis1 and premature death2 ,whereas sickle cell trait 7referred to in this preamble as ,,sct7 occurs when an individual inherits one copy of the sickle cell gene from one parent1 and when both parents have ,,sct1 there is a #be percent chance that any of their children will have ,,scd2 ,whereas there are an estimated #c1jjj1jjj individuals with ,,sct in the ,united ,states1 with many unaware of their status2 ,whereas an estimated #ajj1jjj individuals have ,,scd in the ,united ,states1 with #a out of #cfe ,african-,american births and #a out of #af1cjj ,hispanic-,american births resulting in ,,scd1 and nearly #a out of #ac ,african-,american babies are born with ,,sct2 ,whereas ,,scd affects millions of people throughout the world1 especially individuals of genetic descent from sub-,saharan regions of ,africa1 ,south ,america1 the ,caribbean1 ,central ,america1 ,saudi ,arabia1 ,india1 ,turkey1 ,greece1 and ,italy2 ,whereas the prevalence of ,,sct varies greatly by region1 with rates as high as #dj percent in certain regions of sub-,saharan ,africa1 eastern ,saudi ,arabia1 and central ,india2 ,whereas1 in many countries that are poor in resources1 more than #ij percent of children with ,,scd do not live to see adulthood2 ,whereas approximately #a1jjj children in ,africa are born with ,,scd each day1 more than half of whom will die before their fifth birthday2 ,whereas the high prevalence of ,,scd in the central and western regions of ,india results in approximately #bj percent of babies diagnosed with ,,scd dying before the age of #b2 ,whereas1 in #bjjf1 the ,world ,health ,assembly passed a resolution1 adopted by the ,united ,nations in #bjji1 recognizing ,,scd as a public health priority with a call to action that each country implement measures to tackle the disease2 ,whereas screening newborns for ,,scd is a crucial first step for families to obtain a timely diagnosis and comprehensive care and to decrease the mortality rate of children with ,,scd2 ,whereas approved treatments for ,,scd are limited1 with the ,food and ,drug ,administration approving only #d ,,scd therapies since #bjag1 but there are more than #dj ,,scd therapies in development2 ,whereas there is an immediate need for lifesaving therapeutics that can improve the duration and quality of life of individuals with ,,scd2 ,whereas1 in #bjbj1 the ,national ,academies of ,sciences1 ,engineering1 and ,medicine developed a comprehensive strategic plan and blueprint for action to address ,,scd1 which highlights the need to develop new innovative therapies and to address barriers to the equitable access of approved treatments2 ,whereas1 in #bjbj1 the ,department of ,health and ,human ,services1 in partnership with the ,american ,society of ,hematology and the ,sickle in ,africa ,consortium and in collaboration with the ,world ,health ,organization1 hosted a webinar for a joint effort to strengthen efforts to combat ,,scd during the coronavirus disease 7commonly known as ,,covid-#ai7 pandemic and beyond2 ,whereas the late ,kwaku ,ohene-,frempong1 ,m4,d41 ,professor ,emeritus of ,pediatrics at the ,perelman ,school of ,medicine at the ,university of ,pennsylvania1 an ,american ,society of ,hematology member who served on the ,global ,coalition on ,,scd1 has been a leader in advancing the body of knowledge in ,,scd research1 public health1 and medicine1 and is recognized as immeasurably benefitting thousands of children worldwide2 ,whereas there are emerging genetic therapy technologies1 including gene editing1 that can modify a patient's own hematopoietic stem cells to enable them to generate healthy red blood cells to prevent sickle cell crises2 ,whereas while hematopoietic stem cell transplantation 7commonly known as ,,hsct7 is currently the only cure for ,,scd1 and while advancements in treatment for complications associated with ,,scd have been made1 more research is needed to find widely available and accessible treatments and cures to help individuals with ,,scd2 and ,whereas1 although ,june #ai1 #bjbb1 has been designated as ,world ,sickle ,cell ,awareness ,day to increase public alertness across the ,united ,states and global community about ,,scd1 there remains a continued need for empirical research1 early detection screenings for ,,scd trait carriers1 novel effective treatments leading to a cure1 and preventative care programs with respect to complications from sickle cell anemia and conditions related to ,,scd3 ,now1 therefore1 be it ,that the ,senate-- 7#a7 supports the goals and ideals of ,world ,sickle ,cell ,awareness ,day2 7#b7 commits to ensuring equitable access to new sickle cell disease 7referred to in this resolution as ,,scd7 treatments by shining the light among all economic1 racial1 and ethnic groups to improve health outcomes for those living with ,,scd2 7#c7 calls on the ,department of ,health and ,human ,services to create global policy solutions aimed at providing support for the global community and the domestic resources needed to provide access to newborn screening programs1 therapeutic interventions1 and support services in partnership with local governments2 7#d7 supports eliminating barriers to equitable access for innovative ,,scd therapies1 including cell1 gene1 and gene-editing therapies in the ,medicare and ,medicaid systems for the most vulnerable patients2 7#e7 encourages the people of the ,united ,states and the world to hold appropriate programs1 events1 and activities on ,sickle ,cell ,awareness ,day to raise public awareness of ,,scd traits1 preventative care programs1 treatments1 and other patient services for those suffering from ,,scd1 complications from ,,scd1 and conditions related to ,,scd2 and 7#f7 urges that the options to be considered to combat ,,scd not only address access to potential future curative treatments1 but also address the bias that the population most affected by ,,scd continues to face within the ,united ,states and global healthcare systems4